Skip to main content
Top
Published in: Reactions Weekly 1/2024

01-03-2024 | Naltrexone | Case report

Naltrexone

Eosinophilic pneumonia

Published in: Reactions Weekly | Issue 1/2024

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Ryden AG, et al. When Addiction Medicine and Pulmonary Medicine Intersect: Two Cases of Eosinophilic Pneumonia Secondary to Intramuscular Naltrexone. American Journal of Respiratory and Critical Care Medicine 207: May 2023. Available from: URL: https://dx.doi.org/10.1164/ajrccm-conference.2023.B32 [abstract] Ryden AG, et al. When Addiction Medicine and Pulmonary Medicine Intersect: Two Cases of Eosinophilic Pneumonia Secondary to Intramuscular Naltrexone. American Journal of Respiratory and Critical Care Medicine 207: May 2023. Available from: URL: https://dx.doi.org/10.1164/ajrccm-conference.2023.B32 [abstract]
Metadata
Title
Naltrexone
Eosinophilic pneumonia
Publication date
01-03-2024
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-54216-9

Other articles of this Issue 1/2024

Reactions Weekly 1/2024 Go to the issue

Case report

Pembrolizumab

Case report

Infliximab